Prices delayed by at least 15 minutes | Print
Verici Dx PLC (VRCI)
ORD GBP0.001Open
0.205p
Previous close
0.205p
Trade high
0.2028p
Volume
514,204
Year high
0.979p
Year low
0.1943p
Dividend yield
–
Market capitalisation
£13.66 mn
P/E ratio
2.72
ISIN
GB00BM8HZD43
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Verici Dx PLC is the development of prognostic and diagnostic tests for kidney transplant patients. It is a commercial stage diagnostics company, transforming the outcomes of kidney transplants through a complementary suite of proprietary,edge tests. These form a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. It has developed a suite of blood-based tests for kidney transplant patients. The group has one division being the development of prognostic and diagnostic tests for kidney transplant patients. The company's products are Tutivia, Clarava, Protega. The company's services are Next Generation Sequencing Services, Bioinformatics and Data Science Services.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 13/11/2026 | 11:16:46 | 0.2028 | 500,000 | 1,014.00 |
| 13/11/2026 | 10:46:53 | 0.2 | 13,622 | 27.24 |
| 13/11/2026 | 08:01:54 | 0.2 | 582 | 1.16 |
| 12/11/2026 | 12:56:59 | 0.203 | 49,261 | 100.00 |
| 12/11/2026 | 08:30:30 | 0.2 | 81,300 | 162.60 |